Venture: SIRUM

Investment: $3M grant

Portfolio: Audacious

Investment date: December 2020

Region(s) served: North America

Sector: Healthcare

Core Impact Metric: Patients receiving prescription medication

Providing access to life-saving prescription drugs at affordable prices

By creating a donation, collection, and redistribution platform, SIRUM is catalyzing a secondary market—including stable, transparent pricing and reliable access—for essential medication.

Good Pill is the next phase of their model, an online home delivery pharmacy that leverages a centralized facility and automation to distribute directly to individuals and accelerate national scale.

Why Rippleworks Invested:

SIRUM is the nation’s largest nonprofit medicine redistributor; they’ve built the only end-to-end tracking platform for donated drugs, has patented a tech-enabled medicine donation process, and has provided expert testimony on donation laws for a dozen states.

The result is a scalable public good that drives down the price per prescription, puts life-saving drugs in the hands of low-income Americans, avoids waste and inefficiency of existing health care systems, and puts SIRUM on a path toward financial sustainability over the next 3–5 years.

SIRUM has placed $46 million of prescription medications in the hands of more than 150,000 patients.

Read about Sirum’s other engagements with Rippleworks here and here.


Sign up for our newsletter

Sign up for our newsletter